Region
Featured experience
Meituan $717 million acquisition of Dingdong’s China business
We are advising Meituan on the transaction
MiniMax Group HK$4.8 billion IPO
We advised MiniMax Group on its IPO and HKEX listing
Baidu CNY4.4 billion notes offering
The investment-grade notes are due 2029
Tencent €1.16 billion investment in new Ubisoft subsidiary
We are advising Tencent on the transaction
Fujian Yango $50 million high-yield notes offering
We advised the joint lead managers on the Regulation S offering
China South City Holdings $175 million high-yield notes offering
We advised the initial purchasers on the offering
I-Mab $177 million follow-on secondary offering of ADSs
We advised the underwriters on the equity offering
JOINN Laboratories HK$6.5 billion IPO
We advised JOINN Laboratories on its IPO and HKEX listing.
Victory for PwC China in putative class action
We secured a complete dismissal for PwC China in a lawsuit by Gridsum Holding shareholders
Fantasia $150 million high-yield notes reopening and concurrent tender offer
We advised the initial purchasers on the offering and the dealer managers on the tender offer for Fantasia’s senior notes
InnoCare Pharma HK$3.04 billion share placement
We advised InnoCare Pharma in the placement of new shares
Akeso HK$1.19 billion share placement
We advised the placing agent in the placement of new shares
UP Fintech $65 million convertible notes private placement
We are advising UP Fintech, a Nasdaq-listed online brokerage firm, on its private placement of convertible notes
Youdao $238 million equity follow-on offering
We advised Youdao on its offering of ADSs